Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

1.11
+0.02582.39%
Volume:624.25K
Turnover:686.14K
Market Cap:180.22M
PE:-1.24
High:1.12
Open:1.11
Low:1.08
Close:1.08
52wk High:4.01
52wk Low:0.3600
Shares:162.98M
Float Shares:152.50M
Volume Ratio:0.90
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8943
EPS(LYR):-1.3101
ROE:-85.21%
ROA:-45.11%
PB:1.81
PE(LYR):-0.84

Loading ...

Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities